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CRMP5 (Collapsin Response Mediator Protein 5) Regulates
Dendritic Development and Synaptic Plasticity in the
Cerebellar Purkinje Cells
Naoya Yamashita,1 Bedrich Mosinger,2 Arpita Roy,2Mari Miyazaki,1 Kozue Ugajin,1 Fumio Nakamura,1 Yukio Sasaki,1
Kazuhiko Yamaguchi,3,4 Pappachan Kolattukudy,2 and Yoshio Goshima1
1Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan, 2Burnett
School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32816, 3Laboratory for Memory and Learning,
4Laboratory for Motor Learning Control, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
Collapsin response mediator protein 5 (CRMP5) is one of the CRMP members that expresses abundantly in the developing brain. To
examine the in vivo function of CRMP5, we generated crmp5-deficient (crmp5/) mice. Anti-calbindin immunofluorescence studies of
crmp5/mice revealed aberrant dendrite morphology; specifically, a decrease in the size of soma and diameter of primary dendrite of
the cerebellar Purkinje cells at postnatal day 21 (P21) and P28, but not at P14. Coincidentally, CRMP5 is detected in Purkinje cells at P21
and P28 from crmp5/ mice. In cerebellar slices of crmp5/ mice, the induction of long-term depression of excitatory synaptic
transmission between parallel fibers and Purkinje cells was deficient. Given that brain-derived neurotrophic factor (BDNF) plays major
roles in dendritic development, we tried to elucidate the possible roles of CRMP5 in BDNF signaling. The effect of BDNF to induce
dendritic branching wasmarkedly attenuated in cultured crmp5/ neurons. Furthermore, CRMP5 was tyrosine phosphorylated when
coexpressedwithneurotrophic tyrosine kinase receptor type 2 (TrkB), a receptor forBDNF, inHEK293T cells. These findings suggest that
CRMP5 is involved in the development, maintenance and synaptic plasticity of Purkinje cells.
Introduction
The exquisite formation of the nervous system relies on the
proper arrangement ofmanymorphologically diverse neurons in
several discrete steps. Newborn neurons must migrate to proper
locations, then extend axons and dendrites into proper target
regions, and form synapses with appropriate partners. These
seemingly different processes all depend on the regulation of the
cytoskeleton in response to extra- or intracellular cues that or-
chestrate the morphological development of neurons (Luo,
2000).
Collapsin response mediator protein (CRMP) was originally
identified as a signaling molecule of Semaphorin3A (Sema3A)
(Goshima et al., 1995). CRMPs are now known to be consisted of
five homologous cytosolic proteins CRMP1-5, all of the family
proteins are phosphorylated and are highly expressed in develop-
ing and adult nervous system (Minturn et al., 1995; Byk et al.,
1996; Hamajima et al., 1996; Wang and Strittmatter, 1996;
Fukada et al., 2000; Inatome et al., 2000; Yuasa-Kawada et al.,
2003). Unphosphorylated CRMPs bind with tubulin het-
erodimer, whereas phosphorylation of CRMPs by Rho/ROCK
kinase, cyclin-dependent kinase-5 (Cdk5) and glycogen synthase
kinase-3 (GSK-3) lowers the binding affinity of CRMPs to
tubulin (Fukata et al., 2002; Uchida et al., 2005). Recently, several
knock-out mice studies demonstrated that the loss of CRMPs
causes impaired cell migration, dendritic patterning and spine
development (Charrier et al., 2006; Yamashita et al., 2006; Su et
al., 2007; Yamashita et al., 2007; Quach et al., 2008), suggesting
that CRMPs play an important role in the development of ner-
vous system in vivo.
CRMP5 has been isolated as a CRMP-associated protein, des-
ignated CRAM (Inatome et al., 2000). CRMP5 plays an impor-
tant role in regulating filopodia and growth cone morphology in
neurons (Hotta et al., 2005). Like other types of CRMP family
proteins, CRMP5 is expressed throughout the nervous system
(Wang and Strittmatter, 1996; Fukada et al., 2000). Interestingly,
anti-CRMP5 antibody is often detected in serum of patients with
subacute cerebellar ataxia, and has been recognized as one of the
main antibodies associatedwith paraneoplastic syndromes (Yu et
al., 2001; Cross et al., 2003; Pittock et al., 2004; Honnorat and
Antoine, 2007). However, the in vivo roles of CRMP5 remain
unknown. To address this issue, we first generated crmp5-
deficient (crmp5/)mice, and performed phenotypic analysis of
the mutant mice. We found that dendritic development of Pur-
kinje cells is disturbed during the period of dendritic branching,
and the induction of long-term depression (LTD) of excitatory
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synaptic transmission between parallel fibers and Purkinje cells
was deficient in crmp5/ mice. These findings suggest that
CRMP5 plays a pivotal role in dendritic development and the
function of Purkinje cell in the cerebellum.
Materials andMethods
Materials. Poly-L-lysine and L-glutamine were purchased from Sigma.
Neurobasal medium, B27 and brain-derived neurotrophic factor
(BDNF) were from Invitrogen. Monoclonal antibody against CRMP5
(KZ19) was raised by injecting full-length CRMP5 protein into 129SvE
mouse. No signal was detected in crmp5/ brain lysate (Fig. 1C). Other
antibodies used were as follows: anti-calbindin (D28k; mouse monoclo-
nal, Sigma), anti-microtubule associated protein 2a  2b (MAP2)
(mouse monoclonal, Sigma), anti-p-Tyr (PY99; mouse monoclonal,
Santa Cruz Biotechnology), anti-V5 (mouse monoclonal, Invitrogen),
Alexa Fluor 488- or 594-labeled goat anti-mouse (Invitrogen), and
horseradish peroxidase-labeled sheep anti-mouse (GE Healthcare).
Construction of targeting vector and screening for targeted embryonic
stem cell clones.TheCRMP5 genomic fragmentswere isolated fromR1ES
(embryonic stem) cell DNA by PCR amplification. CRMP5-specific
primers with restriction sites overhangs, derived from the CRMP5
genomic sequence, were used to amplify second and sixth  seventh
introns with adjacent exon sequences (Fig. 1A): K92: CCGCGGCCGC-
CAGATGTGCACAGTGATGTATTGTG, first intron, forward, NotI
site; K90: GCGTCTAGACTTCTCATAGGCTTCCACGAG, second
exon, reverse, Xba1 site; K89: GCGGGATCCTGGTCAATGTGTCTAG-
TATCTCA, sixth exon, forward, BamH1 site; K65: CGCGTCGACT-
GATGTTTTCCAGTCGGTATTCTG; seventh intron, reverse, Sal1 site.
The primer pair K90 and K92 amplified 5 kb fragment corresponding
the first intron and a part of the second exon. The pair K89 and K65
amplified a 3 Kb segment representing part of the sixth exon, sixth in-
tron, seventh exon, and part of the seventh intron. Sequencing of the
PCR products confirmed their identity and revealed the predicted exon/
intron boundaries. The 5 Kb and 3Kb, 5 and 3CRMP5 fragments, were
then inserted into the pIRES—LacZ—neo cassette position such that it
woulddisruptanddelete threeexonsofCRMP5gene(exons3,4,5).HSVTK
genewas added to the 3 end of the construct as a negative selectionmarker.
NotI linearized vector (25 g) was electroporated (240 V, 500F) into 2
107 R1 ES cells (Nagy et al., 1993). The electroporated ES cells were selected
with 150g/ml G418 (active form) and 2 nMGANC.DNA of individual ES
colonies was screened by PCR with a forward neo primer (primer neo5:
TATCGCCTTCTTGACGAGTTCTTCTGA)andaprimer fromtheseventh
intron outside of the homologous region used in the vector (primer K66:
CGCGTCGACATGCTTAACCGAAGGAATTATACCAGAATG). PCR
conditions consisted of 36 cycles of 94°C for 20 s, 63°C for 40 s, and 72°C for
4minusingBRLTaqpolymerase. The recombinationwas confirmedon the
5 end using a forward primer from the first intron outside of the homolo-
gous region used in the construct (primer K91: CCGCGGCCGCTTTGC-
CCATGTGCCTTCTTGACA) and a reverse primer from the internal
ribosomal entry site (IRES) sequence (primer IR: GGGCGGAAT-
TCTCTAGCTAGA). Five positive colonies were identified from
200 colonies screened.
Generation of crmp5 mutant mice. Targeted ES cells were injected into
C57BL/6 blastocysts and implanted into pseudopregnant females. Male
chimeras were mated initially with C57BL/6 females to screen for germ-
line transmission. A transmitting chimeric male was then bred with
129SvE females. Homozygous mutant mice were obtained by intercross-
ing the heterozygotes and screening the progeny by PCR genotyping (Fig.
1B). The wild type allele was amplified by forward primer P1 (CAAGC-
CTGGCTTTTCTCCTGGGTATGT) derived from the portion of the
sixth exon deleted in the targeted allele and reverse primer P2 (CACAT-
GCCCACTGGAACCAGTTTAGCA) derived from the portion of the
sixth intron. The crmp5-deficient allele was amplified by forward primer
P3 (TACCGTAAAGCACGAGGAAGCGGTCA) derived from the por-
tion of neo gene and reverse primer P2 (Fig. 1A).Micewere housed in the
standard mouse facility and fed with autoclaved diet and water. All pro-
cedures were performed according to the guideline outlined in the insti-
tutional Animal Care and Use Committee of the Yokohama City
University School of Medicine. Throughout the experimental proce-
dures, all efforts weremade tominimize the number of animals used and
their suffering. For electrophysiology, we used male mice. For the rest of
the experiments including immunohistochemistry and cell culture, we
did not determine the gender of the mice used.
Immunohistochemistry. Cryostat brain sections (10 m thick) were
treatedwith 0.1%TritonX-100 inTBST for 10min at room temperature.
Immunostaining was performed according to standard protocols using
anti-calbindin (1:500) and anti-CRMP5 (1:200) antibodies. Slides were
analyzed using a laser scanningmicroscope (LSM510) with a 20 objec-
tive (Plan-NEO FLUAR 20x/50) equipped with an Axioplan 2 imaging
microscope (Carl Zeiss). To compare the Purkinje cell morphology, the
long axis of soma and the width of primary dendrite were measured by
using LSM 5 Image software (Carl Zeiss).
Electrophysiology.Mice were anesthetized with ether and decapitated.
The cerebellum was excised and placed in ice-cold artificial CSF (ACSF)
containing the following (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26
NaHCO3, 1 MgSO4, 2 CaCl2, and 20 D-glucose, saturated with 95%
O2/5% CO2. Sagittal slices (300 m) were prepared from the cerebellar
vermis. A whole-cell patch-clamp recordings of Purkinje cells were ob-
tained with glass pipettes (resistance 3–4M) filled with an intrapipette
solution containing the following (in mM): 40 Cs-gluconate, 60 CsCl, 30
HEPES, 0.3 EGTA, 4MgCl2, 4 Na2ATP, 0.4 Na3GTP (pH 7.2 adjusted by
CsOH). Membrane current was recorded in picrotoxin (100 M) con-
taining ACSF at 30°C with a Multiclamp700A amplifier using pClamp 9
software (Molecular Devices). Parallel fibers (PFs) were focally stimu-
lated in the middle molecular layer through glass pipettes.
Primary culture. Hippocampal neurons from E16.5 brains of
crmp5/ or crmp5/ mice were plated on 4-well dishes (Nalgene)
coated with poly-L-lysine at a density of 5 104 cells/well and grown in
Neurobasal medium supplemented with 2% B27 and 0.5 mM
L-glutamine. Cultured neurons were fixed for immunocytochemistry to
estimate the effects of BDNF on primary dendrite formation. BDNF (50
Figure 1. Targeted disruption of the crmp5 gene. A, Structure of thewild type gene, target-
ing vector, and disrupted locus. Positions of oligonucleotide primers used for screening and
confirmation of homologous recombination are indicated. B, Gene types of crmp5/ (left),
crmp5/ (middle), and crmp5/ (right). The 857 bp fragment indicates wild type allele
(primers P1andP2),whereas the1529bp fragment indicates crmp5-deficient allele (primers P3
and P2). C, Immunoblot analysis of anti-CRMP5 antibody in crmp5/ and crmp5/mouse
brain lysates. The final protein amount is 40g each.
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ng/ml) was applied at 3 d in vitro and then cultured for further 3 d before
fixation.
Immunocytochemistry. Cultured neurons were fixed in 2% parafor-
maldehyde for 20 min at room temperature followed by permeabiliza-
tion 0.1% Triton X-100 in PBS. Immunostaining was performed using
anti-MAP2 antibody (1:1000) for counting the number of primary den-
drites per cell in each experimental group. Cells were analyzed using
Olympus IX-71 microscopy using a 10 objective.
In vivo phosphorylation assay.HEK293T cells were seeded at 2.0 105
cells/well in a six-well plate (Nalgene). One day later, the cells were trans-
fected with CRMP5-V5with or without the neurotrophic tyrosine kinase
receptor type 2 (TrkB) expression vector using Fugene6 transfection re-
agent (Roche). After 24 h, cells were lysed by immunoprecipitation
buffer [in mM: 20 Tris-HCl, pH 8.0, 150 NaCl, 1 EDTA, 10 NaF, 1
Na3VO4, 1% Nonidet P-40, 50 p-amidinophenylmethanesulfonyl fluo-
ride (p-APMSF), and 10g/ml aprotinin] and then immunoprecipitated
with 1 g of anti-V5 antibody. The samples were used for immunoblot
analysis of anti-V5 (1:5000) and anti-p-Tyr (1:5000) antibodies.
Statistical significance.Data are shown as mean SEM. The statistical
significance of the results was analyzed using Student’s t test and one-way
ANOVA.
Results
Behavioral disorders in crmp5/mice
To investigate the in vivo function of CRMP5, crmp5/ mice
were generated by homologous recombination using mouse R1
ES cells (Fig. 1A). The crmp5/ mice were normal compared
with its wild-type littermates (data not shown). In addition, the
crmp5/mice appeared normal, without any obvious gross ab-
normalities, they reproduced normally, and their average life
span was almost the same as crmp5/ and wild-type animals
(data not shown). In rotating rod test, no particular impair-
ment of motor coordination was observed in crmp5/ mice
(data not shown).However, adult crmp5/mice showed abnor-
mal limb-clasping reflexes when lifted by the tail. While the adult
crmp5/ mice clasped their hind limbs,
the crmp5/ mice extended their hind
limbs (Fig. 2). This behavioral disorder
may suggest the impairment of the CNS
(Liou et al., 2003; Chen et al., 2005; Kom-
atsu et al., 2006).
Aberrant Purkinje cell morphology in
the crmp5/ cerebellum
Our histological examination using brain
sections stained with cresyl violet revealed
that the gross cytoarchitecture was nor-
mal (data not shown). However, the size
of the Purkinje cell body in crmp5/
mice tends to be smaller than that of
crmp5/ mice at postnatal day 21 (P21)
(Fig. 3). To further investigate this aberrant
Purkinje cell morphology, we performed
immunohistochemistry with anti-calbindin
antibody and measured the long axis of
the Purkinje cell soma and the width of
its primary dendrite. At P21 and P28,
the size of the Purkinje cell body was
smaller and the diameter of its primary
dendrite was thinner in crmp5/ mice
(Fig. 4). Interestingly, these abnormal
phenotypes were not observed in P14
crmp5/ mice (Fig. 4). These results
suggest that the impairment in the Pur-
kinje cells develop after P14.
CRMP5 expression is detected in the cerebellar Purkinje cells
at P21 and P28, but not P14
To elucidate the reason the aberrant morphology of the Purkinje
cell is observed at P21 and P28 but not at P14, we examined
CRMP5 expression profile in the cerebellum with anti-CRMP5
monoclonal antibody. In the cerebellar Purkinje cells, CRMP5
expression is observed in adult mice (Ricard et al., 2001; Bretin et
al., 2005). At P14, the cells surrounding the Purkinje cells were
positively stained with anti-CRMP5 antibody, while signal was
absent in the Purkinje cell in crmp5/mice (Fig. 5A). Interest-
ingly, the Purkinje cells were clearly stained with anti-CRMP5
antibody at P21 andP28 in crmp5/ cerebellum (Fig. 5B,C). No
signal was observed in the crmp5/ cerebellum (Fig. 5D–F),
indicating that the immunoreactive signal of anti-CRMP5 anti-
body is specific to CRMP5. These results suggest that the absence
of CRMP5 may disturb the development of the Purkinje cells
postnatally, especially during dendritic development (McKay
and Turner, 2005).
Figure 2. Abnormal limb-clasping reflex in crmp5/mice. A,B, Limb-clasping reflex test
was performed at P28 in crmp5/ (A) and crmp5/ (B) mice. Abnormal limb-clasping
reflex was observed in eight of 28 crmp5/mice.
Figure 3. Aberrant morphology of Purkinje cells in crmp5/mouse cerebellum. A–D, Nissl staining of the cerebellar cortex
at P21 of crmp5/ (A, C) and crmp5/ (B, D). Magnified images of boxed area in A and B are shown in C and D, respectively.
Arrowhead shows the atrophy of Purkinje cells. Scale bars: (in B), 200m; (in D), 100m. ML, Molecular layer; PL, Purkinje cell
layer; GL, granule cell layer.
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Long-term depression of parallel fibers
and Purkinje cells in crmp5/mice
Since deficits in motor learning is associ-
atedwith physiological deficits of synaptic
plasticity (Ito, 1986; Aiba et al., 1994), we
investigated whether it is possible to in-
duce LTDof excitatory synaptic transmis-
sion between PFs and Purkinje cells in
crmp5/mice. LTDwas induced by con-
junctively applying PF stimuli and depo-
larizing pulses (single pulses, 100 ms
duration; from 70 to 10 mV) at 1 Hz
for 5 min after reaching stable recordings
of EPSCs during PF stimulation at 0.05Hz
for 10 min (Koekkoek et al., 2005). Con-
junctive stimulation induced significant
LTD of PF-EPSCs in Purkinje cell of
crmp5/ (99.9  0.4% during 4 to 0
min; 72.7 3.3% during 26–30 min; n
5, p 	 0.01), but did not induce LTD in
crmp5/ (99.2  0.7% during 4 to 0
min, 92.7 4.2% during 26–30 min; n
6, p
 0.1, n 5) (Fig. 6). The amplitude
of EPSCs measured during 26–30 min af-
ter conjunctive stimulation was signifi-
cantly smaller in crmp5/ than that in
crmp5/ (72.7  3.3% in crmp5/,
92.7  4.2% in crmp5/, p 	 0.05). Ki-
netic properties of PF-PC (Purkinje cell)
EPSCs were examined between crmp5/
and crmp5/, but no significant difference
wasdetected inrising time(10–90%)(1.2
0.1 ms in crmp5/, 1.2  0.1 ms in
crmp5/) nor decay time constant (11.6
1.8 ms in crmp5/, 11.7  2.3 ms in
crmp5/).
Attenuated response to BDNF in
cultured crmp5/ neurons
In addition to being involved in Sema3A
signaling (Goshima et al., 1995; Uchida et
al., 2005), CRMPs are also implicated in
the neurite extension, which is controlled
by a wide range of neurotrophins (Quach
et al., 2004; Yoshimura et al., 2005). One
of the neurotrophins, BDNF, has been
known to play a role in regulating den-
dritic arborization and synaptic neuro-
transmission (Gao et al., 1995; Schwartz et al., 1997; Carter et al.,
2002; Horch and Katz, 2002). We therefore examined the possi-
bility that CRMP5 is involved in neurotrophin signaling. Since
CRMP5 is expressed in Purkinje cells only after P14 (Bretin et al.,
2005;Hotta et al., 2005) (Fig. 5), it is difficult to examine the effect
of BDNF at such elaborate dendritic stage using culture system.
In contrast, CRMP5 is expressed in the early stages of hippocam-
pal development (Hotta et al., 2005). We therefore used hip-
pocampal neurons taken from early embryonic stage (E16.5) for
primary culture neurons and examined the effect of BDNF re-
garding to primary dendrite formation (Cheung et al., 2007).
BDNF, when added to the culture medium, increased the num-
ber of primary dendrites per hippocampal neuron obtained from
crmp5/mice. In contrast, this effect of BDNFwas not observed
in cultured hippocampal neurons from crmp5/mice (Fig. 7A–
E), indicating that CRMP5 was involved in mediating BDNF sig-
naling. In addition, immunohistochemistry with anti-MAP2
antibody showed the MAP2 protein level was decreased in the
hippocampus of crmp5/mouse at P21 when compared with it
of crmp5/mouse (Fig. 7F,G).
CRMP5 is phosphorylated by TrkB in HEK293T cells
Awide variety of biological effects of BDNFaremediated through
TrkB receptor tyrosine kinase, a receptor for BDNF. To further
clarify the role of CRMP5 in BDNF signaling, we examined
whether CRMP5 was phosphorylated by TrkB. In HEK 293T
cells, CRMP5 was tyrosine phosphorylated in the presence of
TrkB (Fig. 7H). This result showed that CRMP5 was phosphor-
ylated by TrkB.
Figure 4. Aberrant morphology of Purkinje cells in crmp5/mouse cerebellum at P21 and P28, but not P14. A–F, Sagittal
sections of the crmp5/ (A–C) and crmp5/ (D–F ) mouse cerebellum at P14 (A, D), P21 (B, E) and P28 (C, F ) stained with
anti-calbindin antibody.G, The Purkinje cells stainedwith anti-calbindin antibody. The length of long axis of the cell body (yellow
line) and the width of the primary dendrites (red line) 20maway from the original point of the initial segment (blue line) were
measured.H, Quantitative data of the length of long axis of the Purkinje cell soma at P14, P21, and P28. In crmp5/, size of the
cell bodies became smaller at P21 and P28. I, Quantitative data of the width of the primary dendrites at P14, P21, and P28. In
crmp5/, the width of the primary dendrites became thinner at P21 and P28. In all cases, three littermates of each
genotype were used for quantification. *p	 0.01 compared with the corresponding value in crmp5/ by Student’s t
test. Scale bar, 50m.
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Discussion
In the present study,we first demonstrate thatCRMP5 is required
for the proper development of the Purkinje cells in the cerebel-
lum, especially during Purkinje cell dendritic branching period.
In P14 crmp5/mice, dendritic arborization and cell morphol-
ogy of the Purkinje cells appeared to be normal, compared with
those in crmp5/ mice. However, in P21 and P28 crmp5/
mice, the soma and dendritic diameter of Purkinje cells were
aberrant (Fig. 4). The morphology changes observed in Purkinje
cells may be related to the expression profile of CRMP5 in devel-
oping cerebellum: CRMP5 was observed at P21 and P28 but not
at P14 of the Purkinje cells (Fig. 5). The coincidental transient
CRMP5 expression profile and the phenotypic defect in crmp5/
mice at the later postnatal stages support the idea that expression of
CRMP5 during a certain period of time is
required for the proper dendritic develop-
ment of Purkinje cells.
We found that the effect of BDNF was
impaired in the cultured hippocampal
neurons from crmp5/ brains (Fig. 7A–
E). In addition, CRMP5 was tyrosine
phosphorylated by TrkB (Fig. 7H). These
findings together suggest that CRMP5
may be involved in BDNF signaling and
together they regulate dendritic morphol-
ogy of the Purkinje cells. The period of
morphological changes observed in
crmp5/ Purkinje cell is well correlated
with the CRMP5 expression profile at the
cerebellar Purkinje cells, though granular
cells expressed CRMP5 even at P14 (Figs.
4, 5). This fact suggests that CRMP5 reg-
ulates dendritic morphology of the Pur-
kinje cells through cell autonomous
effect of BDNF-TrkB signaling. The ex-
pression profile of CRMP5 further sug-
gests that CRMP5 becomes involved in BDNF-TrkB signaling
after P14 (Fig. 5). In the postnatal stage, BDNF-TrkB signaling
regulates dendritic spine density but not dendritic outgrowth
(Shimada et al., 1998). Other CRMP family members, CRMP1
and CRMP3, have shown to positively regulate dendritic spine
density (Yamashita et al., 2006; Quach et al., 2008). Hence, the
loss of CRMP5may impair BDNF-regulated dendritic spine den-
sity and thereby caused impairment of LTD (Fig. 6). Since the
formation of LTD is required for the activity of AMPA-type and
metabotropic glutamate receptors (Raymond et al., 1993), the
suppression of the activity of these receptors can lead to a de-
crease in the diameter of Purkinje cell dendrite (Hirai and
Launey, 2000). The atrophied phenotype seen in the crmp5/
Purkinje cell dendritesmay be therefore explained by the second-
ary effects of impairment of LTD in the crmp5/ cerebellum. In
addition to the possible involvement of CRMP5 in BDNF-TrkB
signaling, CRMP5, may also be a possible modifier of tubulin
(Brot et al., 2010), which may explain the abnormalities in den-
dritic development and impairment of LTD. The behavioral
disorders such as abnormal limb clasping reflexes observed in
crmp5/ mice may be caused by some failure of network
formation and/or synaptic plasticity in the CNS.
CRMP family proteins are consisted of CRMP1-5 and their
splicing variants, each shows distinct distribution patterns in the
peripheral and CNS (Wang and Strittmatter, 1996; Fukada et al.,
2000). Yeast two hybrid and in vitro binding analysis suggest that
the interactions among isoforms favor heterophilic oligomeriza-
tion over homophilic oligomerization (Wang and Strittmatter,
1997). CRMP5 interacts with CRMP2, CRMP3 and CRMP4, but
not with CRMP1 (Fukada et al., 2000). During size exclusion
chromatography, purified bovine CRMP migrates as a tet-
ramer (Wang and Strittmatter, 1997), suggesting that CRMP
family proteins may play their distinct roles by forming
hetero-oligomeric complexes in vivo. To address this issue,
future studies will be required to determine whether there are
genetic interactions among these crmp gene-deficient mutant
mice. In conclusion, CRMP5 plays an important role in den-
dritic development of Purkinje cells in the cerebellum.
CRMP5 probably regulates dendritic development by mediat-
ing BDNF signaling in the CNS.
Figure 5. Expression of CRMP5 in the cerebellar cortex. A–F, The sagittal sections of crmp5/ (A–C) and crmp5/ (D–F )
mice at P14 (A,D), P21 (B, E) and P28 (C, F ) were immunostainedwith anti-CRMP5 antibody. CRMP5was expressed inML and GL
at P14 (A). In addition to ML and GL, CRMP5 was also expressed in PL at P21 and P28 (B, C). No CRMP5 signals were detected in
crmp5/mouse brain (D–F ). Scale bar, 50m.
Figure6. Failure of LTD of PF-PC EPSCs in crmp5/mice. LTD of PF-PC EPSCs is deficient in
crmp5/. Conjunctive stimulation (CJ) induced LTD in crmp5/, but not in crmp5/.
Insets show sample traces of PF-EPSCs taken at time points 1 (black) and 2 (gray) in crmp5/
or at 3 (black) and 4 (gray) in crmp5/.
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